A single dose of AstraZeneca vaccine reduces the likelihood of hospitalization or death in patients with Beta and Gamma variants of the new coronavirus by 82%. This is clear from a statement from the manufacturer.
Loud news about Pfizer and AstraZeneka vaccines against Delta strain
The data are from a study conducted in Canada during the vaccination campaign. The probability of severe illness or death in the Delta and Alpha variants in patients with a single dose of the drug decreases by 87% and 90%, respectively, according to BTA.
The effectiveness of the AstraZeneca vaccine in preventing the development of symptoms of COVID-19 in patients with Beta and Gamma variants is 50%. In the Indian and British versions, it increases to 70% and 72%, respectively.
“Data obtained during the vaccination campaign show that despite the existence of various options that threaten to delay the fight against the pandemic, the vaccine, along with other drugs used in Canada, provides a high level of protection against the most severe forms of the disease, even and after only one dose, “said Mene Pangalos, executive vice president of AstraZeneca.
– .
